Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / UNK||- / OT|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Current Illness: Arterial hypertension (treated with ramipril); Hypothyreosis
Diagnostic Lab Data:
CDC 'Split Type': DEPFIZER INC2021267505
Write-up: died with unknown cause; This is a spontaneous report downloaded from the Agency; Regulatory Authority-WEB [DE-PEI-CADR2021021478]. A non-contactable consumer reported that an 81-year-old female patient received BNT162B2 (COMIRNATY/ mRNA TOZINAMERAN; solution for injection; Lot number: unknown), intramuscular on 15Feb2021 at single dose for COVID-19 immunisation. The patient''s medical history included ongoing arterial hypertension (treated with ramipril) and ongoing hypothyreosis (treated). Concomitant medications were not reported. It was reported that, on 20Feb2021, the patient died with unknown cause. It was unknown if an autopsy was performed or not. The event was assessed as serious (death). The outcome of the event was reported as fatal. Health Authority Comment: Information on risk factors or previous illnesses: Arterial hypertension treated with ramipril treated hypothyroidism / unclear cause of death". No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: died with unknown cause
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166